Skip to Main content Skip to Navigation
New interface
Journal articles

A fully synthetic immunogen carrying a carcinoma-associated carbohydrate for active specific immunotherapy.

Abstract : Aberrant glycosylation of mucins leads to the exposure of cryptic carbohydrate antigens at the surface of carcinoma cells, which, therefore, represent potent targets for anticancer therapeutic vaccines. To date, the development of immunogens to stimulate immune response to such saccharidic antigens is based on carbohydrate conjugation to carrier proteins. However, these traditional protein conjugates are poorly defined in chemical composition and structure. As an alternative, we synthesized a multiple antigenic O-linked glycopeptide (MAG) carrying the carbohydrate Tn antigen associated with a CD4+ T-cell epitope (MAG:Tn-PV). This fully synthetic immunogen is highly defined in composition and carries a high saccharidic epitope ratio over the entire molecule. The MAG:Tn-PV was able to induce anti-Tn IgG antibodies that recognize human tumor cell lines. A therapeutic immunization protocol performed with this fully synthetic immunogen increased the survival of tumor-bearing mice. Thus, the accurately defined and versatile MAG system represents an efficient strategy to induce carbohydrate-specific antitumor immune responses but may also be applicable to the prevention of infectious diseases, if it is based on bacterial oligosaccharides.
Document type :
Journal articles
Complete list of metadata
Contributor : Sylvie Bay Connect in order to contact the contributor
Submitted on : Friday, August 10, 2007 - 3:33:06 PM
Last modification on : Thursday, April 7, 2022 - 10:10:19 AM


  • HAL Id : pasteur-00166858, version 1
  • PUBMED : 10197623



R. Lo-Man, S. Bay, S. Vichier-Guerre, E. Dériaud, D. Cantacuzène, et al.. A fully synthetic immunogen carrying a carcinoma-associated carbohydrate for active specific immunotherapy.. Cancer Research, 1999, 59 (7), pp.1520-4. ⟨pasteur-00166858⟩



Record views